1. Introduction {#sec1}
===============

Esophageal achalasia (EA) is an idiopathic primary esophageal motor disorder characterized by impaired relaxation of the lower esophageal sphincter (LES) and loss of esophageal peristalsis \[[@B1]\]. The classic symptom of EA is dysphagia associated with regurgitation of undigested food. Some patients also experience weight loss, coughing, and chest pain. Although there is no definitive cure, current treatments aim to reduce LES pressure in order to relieve symptoms, improve esophageal emptying, and prevent further esophageal dilation \[[@B2]\]. Treatments include balloon dilation and Heller myotomy with Dor fundoplication.

Patients with EA are at an increased risk for developing squamous cell carcinoma (SCC) of the esophagus, which is thought to be caused by continuous exposure to stagnant ingested food \[[@B3]\]. It has been reported that the frequency of esophageal carcinoma (EC) decreases after surgery for EA \[[@B4]\], but there are several reports of patients diagnosed with EC even after undergoing surgery for EA \[[@B5]--[@B7]\]. To the best of our knowledge, this is the first case report of EC treated with thoracoscopic surgery after Heller-Dor procedure.

2. Case Presentation {#sec2}
====================

A 68-year-old Japanese man diagnosed with EA underwent surgical treatment 33 years ago. During an annual checkup, endoscopy revealed a "0-IIb+IIa" lesion in the middle esophagus ([Figure 1(a)](#fig1){ref-type="fig"}). The patient was referred to our hospital for further evaluation. Iodine staining revealed multiple irregularly shaped iodine-unstained areas spreading to the cervical esophagus ([Figure 1(b)](#fig1){ref-type="fig"}). These areas were biopsied and diagnosed as EC with invasion of the submucosal layer. Barium esophagram ([Figure 2](#fig2){ref-type="fig"}) showed esophageal dilation with a gradual tapering down to the gastroesophageal junction. Emptying of barium to the stomach was normal, owing to the previous surgery. There was a superficial protruding lesion in the midthoracic esophagus (arrowhead). A chest contrast-enhanced computerized tomography scan and positron emission tomography scan showed no lymph node or distant metastases. Early EC (clinical stage I; T1b(SM2)N0M0) was diagnosed based on the 11th edition of the Japanese Classification of Esophageal Carcinoma \[[@B6]\].

Thoracoscopic esophagectomy and open gastric pull-up reconstruction were planned. The thoracic procedure was performed with the patient in the prone position. Mediastinal lymph node dissection was performed, and the esophagus was resected to a level lower than the lesion. Dilation of the esophagus resulted in difficulty with securing the surgical field, but we were able to manage by changing the grasping parts frequently ([Figure 3](#fig3){ref-type="fig"}). The patient was then placed in the supine position and laparotomy was performed. Adhesions were encountered between the lateral segment of the liver and the lesser curvature of the stomach, likely a consequence of the previous abdominal surgery. Through a cervical neck incision, the proximal gastric pull-up was retrieved in the posterior mediastinal pathway and a cervical esophagogastric anastomosis was performed. Additionally, an enteral feeding tube was placed. The total surgical time was 464 minutes and the total estimated blood loss was 100 ml.

Histopathology showed a moderately differentiated SCC invading the submucosal layer (Figures [4(a)](#fig4){ref-type="fig"}① and [4(b)](#fig4){ref-type="fig"}), as well as two SCC invading the mucosal layer ([Figure 4(a)](#fig4){ref-type="fig"}②, ③). There were no lymph node metastases. The final stage was T1b(SM2)N0M0, stage IA. Other histopathologic findings included marked dilation of the upper-middle esophagus and loss of ganglion cells in the myenteric plexus throughout the length of the resected esophagus ([Figure 4(c)](#fig4){ref-type="fig"}) (Grade III at both the dilated part and the nondilated part, according to descriptive rules for achalasia of the esophagus \[[@B1]\]).

The patient\'s postoperative course was uneventful with the exception of mild left recurrent laryngeal nerve paralysis (Clavien-Dindo Grade I). He was discharged on postoperative day 20. Ten months after the surgery, the patient was well without evidence of disease recurrence.

All diagnostic procedures and therapy concerning the patient were carried out after informed consent had been obtained.

3. Discussion {#sec3}
=============

EA is a primary disorder of esophageal motility and is regarded as a risk factor for SCC \[[@B3]\]. In a prospective study, Leeuwenburgh et al. reported that carcinoma develops on average 24 years (range: 10--43) after symptom onset \[[@B6]\]. However, there have been few reports on the results of follow-up after curative surgery for EA and it is unclear whether EC is frequent when EA has been treated successfully. Ellis Jr. et al. reported that the incidence of EC decreased to 0.3% in patients undergoing a second surgery for EA \[[@B4]\]. However, other reports have found that the incidence of carcinoma remained high despite surgery. For example, Arima et al. and Leeuwenburgh et al. reported that, respectively, 15.1 years and 11 years elapsed until the occurrence of EC after surgery for EA \[[@B7], [@B8]\]. Furthermore, Ota et al. reported the results of follow-up after curative surgery for EA. Thirty-two patients underwent long-term and periodic endoscopic follow-up. Esophageal SCC was detected in six patients (18%) and the average duration of follow-up until EC was seen after surgery for EA was 14.3 (5--40) years \[[@B5]\]. Carter and Brewer III reported that EC occurred early (15 months) after surgery for EA, but they considered that it was due to insufficient muscle layer incision \[[@B9]\]. These reports indicate that EC can occur many years after appropriate surgery for EA. In these patients including our case, the Heller-Dor operation was performed as surgical treatment for EA and no patient complained of passage symptoms. This suggests that the potential for malignant transformation persists even after surgery improves passage symptoms. Ribeiro Jr. et al. reported that the esophageal mucosa itself in EA appeared to be associated with malignant potential \[[@B10]\]. Also in our case, passage symptoms are improved after surgery for EA, but barium esophagram showed that esophageal spasm was diffusely observed in the middle and lower esophagus and the dilation of the upper esophagus still remained. From these findings of the barium esophagram, this case is presumed to be Chicago classification type III EA. In addition, ganglion cells were not observed in the myenteric plexus throughout the length of the resected esophagus, which suggests that this case is type III achalasia. Pandolfine et al., who proposed the Chicago classification by high resolution manometry (HRM), reported that type III EA is the most resistant to treatment \[[@B11]\]. Considering these facts, we cannot deny the possibility that chronic inflammation caused by asymptomatic stagnation of food and saliva has remained. HRM was not conducted in our case, but even in EA after surgery, HRM may be useful for monitoring the effect of the surgical treatment and as a predictor of EC. From this point of view, the possibility that food and liquid, including saliva, were retained in the esophagus with no symptoms and that EC occurred on the background of chronic inflammation cannot be denied.

Even after surgery for EA, in many cases, we consider that superficial EC (especially T1a-epithelium or T1a-lamina propria mucosae) can be treated with endoscopic submucosal dissection (ESD). There are several reports on ESD for early EC after surgery for EA \[[@B7], [@B12]\]. Our case was not considered for ESD, because there were multiple lesions spread across a wide area, and part of the lesion invaded deeply. There had been no report on thoracoscopic esophagectomy for EC after surgery for EA, but we could perform it in the prone position and open gastric pull-up reconstruction safely in the present case.

It is important to discover malignancy at earlier stage due to recognition of the risk of developing EC in the patients after surgery for EA and long-term periodic follow-up.
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![Upper gastrointestinal endoscopy showed a "0-IIb+IIa" lesion in the middle esophagus (a). Iodine staining revealed multiple irregularly shaped iodine-unstained areas (b).](CRIS2017-3272014.001){#fig1}

![Barium esophagram showed esophageal dilation with a gradual tapering down to the gastroesophageal junction. There was a superficial protruding lesion in the midthoracic esophagus (arrowhead).](CRIS2017-3272014.002){#fig2}

![Intraoperative findings showed dilated esophagus. We secured the surgical field by elevating the esophagus dorsally and pushing down the trachea ventrally.](CRIS2017-3272014.003){#fig3}

![Resected specimen (a). There are three lesions (①--③) in the markedly dilated esophagus. Moderately differentiated SCC cells invaded the submucosal layer at elevated lesion (b). Loss of ganglion cells in the myenteric plexus throughout the length of the resected esophagus (c).](CRIS2017-3272014.004){#fig4}
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